<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50">
 <label>50.</label>
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>CEPI</collab>
  </person-group>
  <source>CEPI Awards Funding Agreement Worth Up to US$9.5 Million to Colorado State University to Develop a Human Vaccine Against Rift Valley Fever</source>. CEPI (
  <year>2019</year>). Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://cepi.net/news_cepi/cepi-awards-funding-agreement-worth-up-to-us9-5-million-to-colorado-state-university-to-develop-a-human-vaccine-against-rift-valley-fever/" xmlns:xlink="http://www.w3.org/1999/xlink">https://cepi.net/news_cepi/cepi-awards-funding-agreement-worth-up-to-us9-5-million-to-colorado-state-university-to-develop-a-human-vaccine-against-rift-valley-fever/</ext-link> (accessed November 13, 2019).
 </mixed-citation>
</ref>
